Company · CIK 0000886163 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
LIGAND PHARMACEUTICALS INC · LGND
Insider activity reported against this company. All insider holders · Files at: VKTX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 FForm 4 → | Sep 24, 5:22 pm EDT | Martine ZimmermannDirector | 115 | $298.50 | $34,328 | 3,782 | — | |
| Sep 10, 2026 SForm 4 → | Sep 14, 4:59 pm EDT | Martine ZimmermannDirector | 1,200 | $285.00 | $342,000 | 3,897 | −23.5% | |
| Sep 3, 2026 SForm 4 → | Sep 8, 6:34 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $286.09 | $1,430,434 | 36,514 | −12.0% | 10b5-1 |
| Aug 12, 2026 SForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | $292.07 | $9,241,229 | 27,696 | −53.3% | 10b5-1 |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | $56.91 | $1,800,574 | 59,337 | — | 10b5-1 |
| Aug 12, 2026 SForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 7,138 | $292.81 | $2,090,062 | 3,981 | −64.2% | |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 6,138 | $51.56 | $316,475 | 11,119 | — | |
| Aug 3, 2026 SForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $288.99 | $1,444,951 | 41,514 | −10.7% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $52.27 | $261,350 | 46,514 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $313.28 | $1,566,377 | 41,514 | −10.7% | 10b5-1 |
| Jun 30, 2026 JMForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,132 | $55.06 | $282,564 | 46,514 | — | 10b5-1 late |
| Jun 30, 2026 JForm 4 → | Jul 6, 5:11 pm EDT | Octavio EspinozaChief Financial Officer | 17 | $160.71 | $2,732 | 27,696 | — | late |
| Jun 30, 2026 JForm 4 → | Jul 6, 5:10 pm EDT | Todd C DavisChief Executive Officer, Director | 132 | $160.71 | $21,214 | 199,513 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 MForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | — | — | 0 | — | 10b5-1 |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 6,138 | — | — | 0 | — | |
| Aug 3, 2026 MForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | — | — | 29,444 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | — | — | 34,444 | — | 10b5-1 |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.